Pyrrolidines As Main Protease Inhibitors for Treating Viral Infections, in Particular, Coronavirus Infections
Overview
Overview
Journal
ACS Med Chem Lett
Publisher
American Chemical Society
Specialty
Chemistry
Date
2024 Dec 18
PMID
39691512
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Provided herein are novel pyrrolidines as main protease inhibitors, pharmaceutical compositions, use of such compounds in treating viral infections, in particular, coronavirus infections, and processes for preparing such compounds.
References
1.
Liu L, Kapralov M, Ashton M
. Plant-derived compounds as potential leads for new drug development targeting COVID-19. Phytother Res. 2024; 38(3):1522-1554.
DOI: 10.1002/ptr.8105.
View
2.
Sabnis R
. Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections. ACS Med Chem Lett. 2024; 15(8):1186-1187.
PMC: 11318001.
DOI: 10.1021/acsmedchemlett.4c00331.
View
3.
Kerti L, Frecer V
. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure-activity relationships. Bioorg Med Chem. 2024; 113:117909.
DOI: 10.1016/j.bmc.2024.117909.
View
4.
Liu X, Ren X, Hua M, Liu F, Ren X, Sui C
. Progress of SARS-CoV-2 Main protease peptide-like inhibitors. Chem Biol Drug Des. 2023; 103(1):e14425.
DOI: 10.1111/cbdd.14425.
View
5.
Li Y, Lu S, Wang J, Yao H, Liang L
. Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19. Heliyon. 2024; 10(12):e33179.
PMC: 11253070.
DOI: 10.1016/j.heliyon.2024.e33179.
View